Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
7 Apr 2017
Acquisition of own shares
Read More
4 Apr 2017
UCB and Q-State Biosciences Form Research Collaboration to Develop Novel Therapeutics for Genetic Subtypes of Epilepsy
Read More
1 Apr 2017
UCB AND AMGEN REPORT NEW DATA AT ENDO 2017 EXAMINING THE OPTION OF A SECOND COURSE OF TREATMENT WITH EVENITY™* (ROMOSOZUMAB)
Read More
24 Mar 2017
UCB General Meeting on 27 April 2017
Read More
24 Mar 2017
Headline
Read More
22 Mar 2017
U.S. Patent and Trademark Office confirms validity of patent for UCB's Vimpat®
Read More
16 Mar 2017
Transparency notifications
Read More
10 Mar 2017
Transparency notification
Read More
10 Mar 2017
Acquisition of own shares
Read More
9 Mar 2017
Transparency notification
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
32
Page
33
Page
34
Page
35
Current page
36
Page
37
Page
38
Page
39
Page
40
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss